Home4AB • FRA
add
AbbVie Inc
Nakaraang pagsara
€194.60
Sakop ng araw
€192.20 - €195.40
Sakop ng taon
€147.00 - €209.50
Market cap
404.51B USD
Average na Volume
291.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Sa balita
Investing.com
8 oras ang nakalipas
Abbvie stock price target raised to $250 from $236 at Raymond James
0.89%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 15.42B | 6.65% |
Gastos sa pagpapatakbo | 5.29B | 0.53% |
Net na kita | 938.00M | -31.53% |
Net profit margin | 6.08 | -35.80% |
Kita sa bawat share | 2.97 | 12.08% |
EBITDA | 7.84B | 9.93% |
Aktuwal na % ng binabayarang buwis | 39.45% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.47B | -50.85% |
Kabuuang asset | 137.18B | -3.35% |
Kabuuang sagutin | 137.32B | 1.63% |
Kabuuang equity | -138.00M | — |
Natitirang share | 1.77B | — |
Presyo para makapag-book | -1.95K | — |
Return on assets | 10.59% | — |
Return on capital | 20.39% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 938.00M | -31.53% |
Cash mula sa mga operasyon | 5.15B | 126.90% |
Cash mula sa pag-invest | -1.18B | -7.17% |
Cash mula sa financing | -2.71B | 55.55% |
Net change in cash | 1.29B | 126.17% |
Malayang cash flow | 6.02B | 105.93% |
Tungkol
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Itinatag
Abr 10, 2012
Headquarters
Website
Mga Empleyado
55,000
